Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

力邦喜通 - NMPA Drug Approval Details

Approvals/NMPA/Alprostadil Injection

Approved

化学药品

Alprostadil Injection

西安力邦制药有限公司,西安汉丰药业有限责任公司🇨🇳 National Medical Products Administration

Approval Date: Jan 3, 2020
Approval ID: 7LeaffrxRFS
Company: 西安力邦制药有限公司,西安汉丰药业有限责任公司
Type: 化学药品

Approval Details

Approval Id: 7LeaffrxRFS
Approval Number: 国药准字H20103101
Generic Name: 前列地尔注射液
Generic Name En: Alprostadil Injection
Brand Name: 力邦喜通
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 1ml:5μg
Reg Date: 2020-01-03
Company Name: 西安力邦制药有限公司,西安汉丰药业有限责任公司
Production Company Name: 西安力邦制药有限公司,西安汉丰药业有限责任公司
Production Company Address: 西安市高新区科技一路22号,西安市蓝田县工业园区文姬路15号

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 3, 2020

Approval ID

7LeaffrxRFS

Type

化学药品

Back to NMPA Approvals